Enfusion

Enfusion Equity

Delisted

The The Equity of Enfusion (ENFN) as of Nov 7, 2026 is 73.22 M USD. In the previous year, The Equity was 53.67 M USD — a change of 36.44% (higher).

Equity

73.22 MUSD

YoY

36.44%

Last updated:

In 2024, Enfusion's equity was 73.22 M USD, a 36.44% increase from the 53.67 M USD equity in the previous year.

The Enfusion Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
-117.88 M USD
Jan 1, 2020
-233.56 M USD
Jan 1, 2021
55.29 M USD
Jan 1, 2022
65.01 M USD
Jan 1, 2023
53.67 M USD
Jan 1, 2024
73.22 M USD
The Enfusion Equity history
YEAREquityYoY
73.22 MUSD+36.44%
53.67 MUSD-17.45%
65.01 MUSD+17.57%
55.29 MUSD-123.67%
-233.56 MUSD+98.13%
-117.88 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Enfusion's Equity

Enfusion's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Enfusion's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Enfusion's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Enfusion's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Enfusion’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Enfusion stock

The Equity of Enfusion is 73.22 M USD in 2024.

The Equity of Enfusion changed from 53.67 M USD to 73.22 M USD, representing a 36.44% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Enfusion since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Enfusion historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Enfusion

All Key Metrics — Enfusion